Clinical Psychopharmacology and Neuroscience indexed in CAS, DOI/Crossref, EMBASE, Korea Citation Index (KCI), KoreaMed, Korea Medical Citation Index (KoMCI), PubMed, PubMed Central (PMC), SCOPUS, SCI-expanded (SCIE), and Google Scholar:eISSN 2093-4327   pISSN 1738-1088

Cited by CrossRef (107)

  1. Babu Swathy, Moinak Banerjee. Understanding Pharmaco-Epigenomic Response of Antipsychotic Drugs Using Genome-Wide MicroRNA Expression Profile in Liver Cell Line. Front. Mol. Neurosci. 2022;15
    https://doi.org/10.3389/fnmol.2022.786632
  2. Adela Magdalena Ciobanu, Vlad Dionisie, Cristina Neagu, Otilia Maria Bolog, Sorin Riga, Ovidiu Popa-Velea. Psychopharmacological Treatment, Intraocular Pressure and the Risk of Glaucoma: A Review of Literature. JCM 2021;10:2947
    https://doi.org/10.3390/jcm10132947
  3. Graham Blackman, Jenny E.L. Lisshammar, Rayyan Zafar, Thomas A. Pollak, Megan Pritchard, Alexis E. Cullen, Jonathan Rogers, Ben Carter, Kira Griffiths, Matthew Nour, Anthony S. David, Philip McGuire, Robert Stewart, James MacCabe. Clozapine Response in Schizophrenia and Hematological Changes. J Clin Psychopharmacol 2021;41:19
    https://doi.org/10.1097/JCP.0000000000001329
  4. Kuo-Hsuan Chung, Pao-Huan Chen, Chian-Jue Kuo, Shang-Ying Tsai, Shou-Hung Huang, Wen-Cheng Wu. Risk factors for early circulatory mortality in patients with schizophrenia. Psychiatry Research 2018;267:7
    https://doi.org/10.1016/j.psychres.2018.05.044
  5. Reza Bahramabadi, Morteza Samadi, Alireza Vakilian, Elham Jafari, Mahmood Sheikh Fathollahi, Mohammad Kazemi Arababadi. Evaluation of the effects of anti-psychotic drugs on the expression of CD68 on the peripheral blood monocytes of Alzheimer patients with psychotic symptoms. Life Sciences 2017;179:73
    https://doi.org/10.1016/j.lfs.2017.04.024
  6. Chi-Yu Lai, Elizabeth Scarr, Madhara Udawela, Ian Everall, Wei J Chen, Brian Dean. Biomarkers in schizophrenia: A focus on blood based diagnostics and theranostics. WJP 2016;6:102
    https://doi.org/10.5498/wjp.v6.i1.102
  7. Elisa Guma, Eric Plitman, M Mallar Chakravarty. The role of maternal immune activation in altering the neurodevelopmental trajectories of offspring: A translational review of neuroimaging studies with implications for autism spectrum disorder and schizophrenia. Neuroscience & Biobehavioral Reviews 2019;104:141
    https://doi.org/10.1016/j.neubiorev.2019.06.020
  8. Yunlong Tan, Yanli Li, Shuping Tan, Zhiren Wang, Fu-De Yang, Bo Cao, Giovana B. Zunta-Soares, Jair C. Soares, Xiang Yang Zhang. Increased interleukin-2 serum levels were associated with psychopathological symptoms and cognitive deficits in treatment-resistant schizophrenia. Schizophrenia Research 2015;169:16
    https://doi.org/10.1016/j.schres.2015.10.038
  9. Alexander E Ryan, Bryan J Mowry, James P Kesby, James G Scott, Judith M Greer. Is there a role for antibodies targeting muscarinic acetylcholine receptors in the pathogenesis of schizophrenia?. Aust N Z J Psychiatry 2019;53:1059
    https://doi.org/10.1177/0004867419864438
  10. Chihiro Nakagawa, Satoshi Yokoyama, Kouichi Hosomi, Mitsutaka Takada. Repurposing haloperidol for the treatment of rheumatoid arthritis: an integrative approach using data mining techniques. Therapeutic Advances in Musculoskeletal 2021;13:1759720X2110470
    https://doi.org/10.1177/1759720X211047057
  11. Emily J. Jaehne, Frances Corrigan, Catherine Toben, M. Catharine Jawahar, Bernhard T. Baune. The effect of the antipsychotic drug quetiapine and its metabolite norquetiapine on acute inflammation, memory and anhedonia. Pharmacology Biochemistry and Behavior 2015;135:136
    https://doi.org/10.1016/j.pbb.2015.05.021
  12. Meghan May, Megan Beauchemin, Calvin Vary, Deborah Barlow, Karen L. Houseknecht, Vincenzo De Luca. The antipsychotic medication, risperidone, causes global immunosuppression in healthy mice. PLoS ONE 2019;14:e0218937
    https://doi.org/10.1371/journal.pone.0218937
  13. Anwesha Gangopadhyay, Radwa Ibrahim, Karli Theberge, Meghan May, Karen L. Houseknecht. Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines. Front. Neurosci. 2022;16
    https://doi.org/10.3389/fnins.2022.1042442
  14. G. Fond, N. Resseguier, F. Schürhoff, O. Godin, M. Andrianarisoa, L. Brunel, E. Bulzacka, B. Aouizerate, F. Berna, D. Capdevielle, I. Chereau, T. D’Amato, C. Dubertret, J. Dubreucq, C. Faget, F. Gabayet, C. Lançon, P. M. Llorca, J. Mallet, D. Misdrahi, C. Passerieux, R. Rey, A. Schandrin, M. Urbach, P. Vidailhet, L. Boyer, M. Leboyer. Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort. Eur Arch Psychiatry Clin Neurosci 2018;268:541
    https://doi.org/10.1007/s00406-017-0847-1
  15. Manjula Subbanna, Venkataram Shivakumar, Deepthi Venugopal, Janardhanan C. Narayanaswamy, Michael Berk, Shivarama Varambally, Ganesan Venkatasubramanian, Monojit Debnath. Impact of antipsychotic medication on IL‐6/STAT3 signaling axis in peripheral blood mononuclear cells of drug‐naive schizophrenia patients. Psychiatry Clin Neurosci 2020;74:64
    https://doi.org/10.1111/pcn.12938
  16. Ruth Elliesen, Andreas Walther. Commentary: Physical Functional Capacity and C-Reactive Protein in Schizophrenia. Front. Psychiatry 2018;9
    https://doi.org/10.3389/fpsyt.2018.00007
  17. Adonis Sfera, Sabine Hazan, Jonathan J. Anton, Dan O. Sfera, Christina V. Andronescu, Sarvin Sasannia, Leah Rahman, Zisis Kozlakidis. Psychotropic drugs interaction with the lipid nanoparticle of COVID-19 mRNA therapeutics. Front. Pharmacol. 2022;13
    https://doi.org/10.3389/fphar.2022.995481
  18. Giuseppe Caruso, Margherita Grasso, Annamaria Fidilio, Fabio Tascedda, Filippo Drago, Filippo Caraci. Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia. Pharmaceuticals 2020;13:457
    https://doi.org/10.3390/ph13120457
  19. Evgeny Ermakov, Mark Melamud, Anastasiia Boiko, Daria Kamaeva, Svetlana Ivanova, Georgy Nevinsky, Valentina Buneva. Association of Peripheral Inflammatory Biomarkers and Growth Factors Levels with Sex, Therapy and Other Clinical Factors in Schizophrenia and Patient Stratification Based on These Data. Brain Sciences 2023;13:836
    https://doi.org/10.3390/brainsci13050836
  20. Md. Mamun Al-Amin, Md. Faiyad Rahman Choudhury, Al Saad Chowdhury, Tahsinur Rahman Chowdhury, Preeti Jain, Mohsin Kazi, Musaed Alkholief, Sultan M. Alshehri, Hasan Mahmud Reza. Pretreatment With Risperidone Ameliorates Systemic LPS-Induced Oxidative Stress in the Cortex and Hippocampus. Front. Neurosci. 2018;12
    https://doi.org/10.3389/fnins.2018.00384
  21. Yilin Tao, Peng Xu, Weiyi Zhu, Zhiyue Chen, Xiaohan Tao, Jiajing Liu, Ziru Xue, Tao Zhu, Peifang Jiang. Changes of Cytokines in Children With Tic Disorder. Front. Neurol. 2022;12
    https://doi.org/10.3389/fneur.2021.800189
  22. Deborah Wenk, Shahbaz Khan, Vladimir Ignatchenko, Harald Hübner, Peter Gmeiner, Dorothee Weikert, Monika Pischetsrieder, Thomas Kislinger. Phosphoproteomic Analysis of Dopamine D2 Receptor Signaling Reveals Interplay of G Protein- and β-Arrestin-Mediated Effects. J. Proteome Res. 2023;22:259
    https://doi.org/10.1021/acs.jproteome.2c00707
  23. Marco Ferrari, Marco Godio, Stefano Martini, Camilla Callegari, Marco Cosentino, Franca Marino. Effect of quetiapine on inflammation and immunity: a systematic review. International Journal of Psychiatry in Clinical Practice 2023;27:196
    https://doi.org/10.1080/13651501.2022.2101928
  24. E. Carla Parker-Athill, Jared Ehrhart, Jun Tan, Tanya K. Murphy. Cytokine Correlations in Youth with Tic Disorders. Journal of Child and Adolescent Psychopharmacology 2015;25:86
    https://doi.org/10.1089/cap.2014.0103
  25. Destanie R. Rose, Milo Careaga, Judy Van de Water, Kim McAllister, Melissa D. Bauman, Paul Ashwood. Long-term altered immune responses following fetal priming in a non-human primate model of maternal immune activation. Brain, Behavior, and Immunity 2017;63:60
    https://doi.org/10.1016/j.bbi.2016.11.020
  26. Hong Shen, Danyang Wu, Shanshan Wang, Mengjie Zhao, Wenbo Sun, Xiaozhou Zhu, Ning Zhang, Hui Yao, Qing Cui, Hong Xiao. Atypical Antipsychotic Administration in Schizophrenic Patients Leads to Elevated Lipoprotein‐Associated Phospholipase A2 Levels and Increased Cardiovascular Risk: A Retrospective Cohort Study. Basic Clin Pharma Tox 2018;123:756
    https://doi.org/10.1111/bcpt.13079
  27. Jobbe Goossens, Manuel Morrens, Violette Coppens. The Potential Use of Peripheral Blood Mononuclear Cells as Biomarkers for Treatment Response and Outcome Prediction in Psychiatry: A Systematic Review. Mol Diagn Ther 2021;25:283
    https://doi.org/10.1007/s40291-021-00516-8
  28. Célia Fourrier, Catherine Toben, Bernhard T. Baune. Textbook of Immunopsychiatry. 2021.
    https://doi.org/10.1017/9781108539623.016
  29. Seong Hoon Jeong, Yong Sik Kim. Challenges in Prescribing Clozapine in the Era of COVID-19: A Review Focused on Immunological Implications. Clin Psychopharmacol Neurosci 2021;19:411
    https://doi.org/10.9758/cpn.2021.19.3.411
  30. Anne Uhlmann, Jean-Paul Fouche, Katharina Lederer, Ernesta M. Meintjes, Don Wilson, Dan J. Stein. White matter microstructure and impulsivity in methamphetamine dependence with and without a history of psychosis. Hum. Brain Mapp. 2016;37:2055
    https://doi.org/10.1002/hbm.23159
  31. Michele Persico, Claudia Abbruzzese, Silvia Matteoni, Paola Matarrese, Anna Maria Campana, Veronica Villani, Andrea Pace, Marco G. Paggi. Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma. Cells 2022;11:263
    https://doi.org/10.3390/cells11020263
  32. Luiz Dratcu, Xavier Boland. Does Nicotine Prevent Cytokine Storms in COVID-19?. 2020
    https://doi.org/10.7759/cureus.11220
  33. Miguel Angel Ramos-Méndez, Carlos Alfonso Tovilla-Zárate, Isela Esther Juárez-Rojop, María Lilia López-Narváez, Alma Delia Genis-Mendoza, Thelma Beatriz González-Castro, José Jaime Martínez-Magaña, Guillermo Efrén Villar-Juárez, Marcela Bellizzia-Rodríguez, Rosa Giannina Castillo-Avila, Yazmin Hernández-Díaz, Rosa Felicita Ortiz Ojeda. Increased Interleukins: Effect of Risperidone in Individuals with Schizophrenia—a Systematic Review. SN Compr. Clin. Med. 2023;5
    https://doi.org/10.1007/s42399-023-01479-z
  34. Hiram Tendilla-Beltrán, Silvia Meneses-Prado, Rubén Antonio Vázquez-Roque, Miguel Tapia-Rodríguez, Andrea Judith Vázquez-Hernández, Heriberto Coatl-Cuaya, David Martín-Hernández, Karina S. MacDowell, Linda Garcés-Ramírez, Juan C. Leza, Gonzalo Flores. Risperidone Ameliorates Prefrontal Cortex Neural Atrophy and Oxidative/Nitrosative Stress in Brain and Peripheral Blood of Rats with Neonatal Ventral Hippocampus Lesion. J. Neurosci. 2019;39:8584
    https://doi.org/10.1523/JNEUROSCI.1249-19.2019
  35. Jaśmina Arabska, Anna Łucka, Radosław Magierski, Tomasz Sobów, Adam Wysokiński. Neutrophil-lymphocyte ratio is increased in elderly patients with first episode depression, but not in recurrent depression. Psychiatry Research 2018;263:35
    https://doi.org/10.1016/j.psychres.2018.02.043
  36. Chor Hong Lim, Nor Zuraida Zainal, Sharmilla Kanagasundram, Shamsul Mohd Zain, Zahurin Mohamed. Preliminary examination of microRNA expression profiling in bipolar disorder I patients during antipsychotic treatment. American J of Med Genetics Pt B 2016;171:867
    https://doi.org/10.1002/ajmg.b.32457
  37. Jessenia Morillo, Valery Morillo, Maria Angelica Marquina, Milagros Rojas, Manuel Nava. Use of Psychotropics in COVID-19: Another Anti-inflammatory Pathway. CPRR 2023;19:137
    https://doi.org/10.2174/2666082218666220812114149
  38. Kyle J. Burghardt, Audrey S. Khoury, Zaher Msallaty, Zhengping Yi, Berhane Seyoum. Antipsychotic Medications and DNA Methylation in Schizophrenia and Bipolar Disorder: A Systematic Review. Pharmacotherapy 2020;40:331
    https://doi.org/10.1002/phar.2375
  39. Rick Wilhiam de Camargo, Marina Goulart da Silva, Guilherme Cabreira Daros, Fabiana Durante de Medeiros, Naiana da Rosa, Caroline Liana Menschhein Medeiros, Eduardo de Medeiros Peretti, Juliete Palandi, Franciane Bobinski, Jucélia Jeremias Fortunato, Rafael Mariano de Bitencourt. Effects of Chronic Administration of P-Cymene in an Animal Model of LPS-Induced Autism. Planta Medica International Open 2021;8:e104
    https://doi.org/10.1055/a-1491-1866
  40. Xiaoxiao Sun, Guoshuai Luo, Xue Li, Jiayue Wang, Yuying Qiu, Meijuan Li, Jie Li. The relationship between inflammatory markers, clinical characteristics, and cognitive performance in drug-naïve patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci 2023
    https://doi.org/10.1007/s00406-023-01677-9
  41. Y Zhang, V S Catts, D Sheedy, T McCrossin, J J Kril, C Shannon Weickert. Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation. Transl Psychiatry 2016;6:e982
    https://doi.org/10.1038/tp.2016.238
  42. Laura K Green, Pirooz Zareie, Nikki Templeton, Robert A Keyzers, Bronwen Connor, Anne Camille La Flamme. Enhanced disease reduction using clozapine, an atypical antipsychotic agent, and glatiramer acetate combination therapy in experimental autoimmune encephalomyelitis. Multiple Sclerosis Journal - Experimental, Translational and Clinical 2017;3:205521731769872
    https://doi.org/10.1177/2055217317698724
  43. Benjamin I. Goldstein, Bernhard T. Baune, David J. Bond, Pao‐Huan Chen, Lisa Eyler, Andrea Fagiolini, Fabiano Gomes, Tomas Hajek, Jessica Hatch, Susan L. McElroy, Roger S. McIntyre, Miguel Prieto, Louisa G. Sylvia, Shang‐Ying Tsai, Andrew Kcomt, Jess G. Fiedorowicz. Call to action regarding the vascular‐bipolar link: A report from the Vascular Task Force of the International Society for Bipolar Disorders. Bipolar Disorders 2020;22:440
    https://doi.org/10.1111/bdi.12921
  44. Deborah Wenk, Vladimir Ignatchenko, Andrew Macklin, Harald Hübner, Peter Gmeiner, Dorothée Weikert, Monika Pischetsrieder, Thomas Kislinger. Functionally selective activation of the dopamine receptor D2 is mirrored by the protein expression profiles. Sci Rep 2021;11
    https://doi.org/10.1038/s41598-021-83038-x
  45. João V. Nani, Priscila G. C Almeida, Cristiano Noto, Rodrigo A. Bressan, Elisa Brietzke, Mirian A. F Hayashi. Unraveiling the correlation among neurodevelopmental and inflammatory biomarkers in patients with chronic schizophrenia. Nordic Journal of Psychiatry 2022;76:559
    https://doi.org/10.1080/08039488.2021.2023217
  46. J. Cho, R. D. Hayes, A. Jewell, G. Kadra, H. Shetty, J. H. MacCabe, J. Downs. Clozapine and all‐cause mortality in treatment‐resistant schizophrenia: a historical cohort study. Acta Psychiatr Scand 2019;139:237
    https://doi.org/10.1111/acps.12989
  47. Giulia Tronchin, Theophilus N. Akudjedu, Mohamed Ahmed, Laurena Holleran, Brian Hallahan, Dara M. Cannon, Colm McDonald. Progressive subcortical volume loss in treatment-resistant schizophrenia patients after commencing clozapine treatment. Neuropsychopharmacol. 2020;45:1353
    https://doi.org/10.1038/s41386-020-0665-4
  48. Marcella Reale, Erica Costantini, Nigel H. Greig. Cytokine Imbalance in Schizophrenia. From Research to Clinic: Potential Implications for Treatment. Front. Psychiatry 2021;12
    https://doi.org/10.3389/fpsyt.2021.536257
  49. Hasan Yousefi-Manesh, Pegah Dejban, Faiza Mumtaz, Alireza Abdollahi, Mohsen Chamanara, Ahmadreza Dehpour, Amin Hasanvand, Amir Rashidian. Risperidone attenuates acetic acid-induced colitis in rats through inhibition of TLR4/NF-kB signaling pathway. Immunopharmacology and Immunotoxicology 2020;42:464
    https://doi.org/10.1080/08923973.2020.1808987
  50. Ellen Ji, Danny Boerrigter, Helen Q. Cai, David Lloyd, Jason Bruggemann, Maryanne O'Donnell, Cherrie Galletly, Andrew Lloyd, Dennis Liu, Rhoshel Lenroot, Thomas W. Weickert, Cynthia Shannon Weickert. Peripheral complement is increased in schizophrenia and inversely related to cortical thickness. Brain, Behavior, and Immunity 2022;101:423
    https://doi.org/10.1016/j.bbi.2021.11.014
  51. Gabriel R. Fries, Dimitre H. Dimitrov, Shuko Lee, Nicole Braida, Jesse Yantis, Craig Honaker, Joe Cuellar, Consuelo Walss-Bass. Genome-wide expression in veterans with schizophrenia further validates the immune hypothesis for schizophrenia. Schizophrenia Research 2018;192:255
    https://doi.org/10.1016/j.schres.2017.06.016
  52. Lyndsey E. Wessels, James D. Wallace, Richard Y. Calvo, Tatyana Levko, Jason M. Bowie, William J. Butler, Vishal Bansal, C. Beth Sise, Matthew J. Martin, Michael J. Sise. Quetiapine therapy in critically injured trauma patients is associated with an increased risk of pulmonary complications. The American Journal of Surgery 2020;219:804
    https://doi.org/10.1016/j.amjsurg.2020.02.033
  53. Anne C La Flamme, David Abernethy, Dalice Sim, Liz Goode, Michelle Lockhart, David Bourke, Imogen Milner, Toni-Marie Garrill, Purwa Joshi, Eloise Watson, Duncan Smyth, Sean Lance, Bronwen Connor. Safety and acceptability of clozapine and risperidone in progressive multiple sclerosis: a phase I, randomised, blinded, placebo-controlled trial. BMJ Neurol Open 2020;2:e000060
    https://doi.org/10.1136/bmjno-2020-000060
  54. Kirsten E. Schoonover, Laura J. McMeekin, Charlene B. Farmer, Neelu E. Varghese, Stacy L. Queern, Suzanne E. Lapi, Rita M. Cowell, Rosalinda C. Roberts. Interactions between knockout of schizophrenia risk factor Dysbindin-1 and copper metabolism in mice. Brain Research Bulletin 2020;164:339
    https://doi.org/10.1016/j.brainresbull.2020.07.024
  55. Xiaoyu Zhu, Ran Li, Yu Zhu, Jia Zhou, Junchao Huang, Yanfang Zhou, Jinghui Tong, Ping Zhang, Xingguang Luo, Song Chen, Yanli Li, Baopeng Tian, Shu-Ping Tan, Zhiren Wang, Xiaole Han, Li Tian, Chiang-Shan R Li, Yun-Long Tan. Changes in Inflammatory Biomarkers in Patients with Schizophrenia: A 3-Year Retrospective Study. NDT 2023;Volume 19:1597
    https://doi.org/10.2147/NDT.S411028
  56. Sergey N. Mosolov, Elizaveta Yu. Fedorova. The risk of developing cardiovascular disease in bipolar disorder. Biological factors and therapy. Terapevticheskii arkhiv 2022;94:579
    https://doi.org/10.26442/00403660.2022.04.201455
  57. Shvetank Bhatt, Arghya Kusum Dhar, Malay Kumar Samanta, Ashish Suttee. Neuroinflammation, Gut-Brain Axis and Immunity in Neuropsychiatric Disorders. 2022.
    https://doi.org/10.1007/978-981-19-7376-5_18
  58. Caitlin E. Murphy, Adam K. Walker, Maryanne O’Donnell, Cherrie Galletly, Andrew R. Lloyd, Dennis Liu, Cynthia Shannon Weickert, Thomas W. Weickert. Peripheral NF-κB dysregulation in people with schizophrenia drives inflammation: putative anti-inflammatory functions of NF-κB kinases. Transl Psychiatry 2022;12
    https://doi.org/10.1038/s41398-021-01764-2
  59. Vijayasree V. Giridharan, Giselli Scaini, Gabriela D. Colpo, Tejaswini Doifode, Omar F. Pinjari, Antônio L. Teixeira, Fabricia Petronilho, Danielle Macêdo, João Quevedo, Tatiana Barichello. Clozapine Prevents Poly (I:C) Induced Inflammation by Modulating NLRP3 Pathway in Microglial Cells. Cells 2020;9:577
    https://doi.org/10.3390/cells9030577
  60. Samantha Alvarez-Herrera, Raúl Escamilla, Oscar Medina-Contreras, Ricardo Saracco, Yvonne Flores, Gabriela Hurtado-Alvarado, José Luis Maldonado-García, Enrique Becerril-Villanueva, Gilberto Pérez-Sánchez, Lenin Pavón. Immunoendocrine Peripheral Effects Induced by Atypical Antipsychotics. Front. Endocrinol. 2020;11
    https://doi.org/10.3389/fendo.2020.00195
  61. Pirooz Zareie, Bronwen Connor, Anne Camille La Flamme. Amelioration of experimental autoimmune encephalomyelitis by clozapine is not associated with defective CD4 T cell responses. J Neuroinflammation 2017;14
    https://doi.org/10.1186/s12974-017-0842-5
  62. R. Emsley, L. Asmal, S. du Plessis, B. Chiliza, L. Phahladira, S. Kilian. Brain volume changes over the first year of treatment in schizophrenia: relationships to antipsychotic treatment. Psychol. Med. 2017;47:2187
    https://doi.org/10.1017/S0033291717000642
  63. Mohammad Mahdi Eftekharian, Mir Davood Omrani, Shahram Arsang-Jang, Mohammad Taheri, Soudeh Ghafouri-Fard. Serum cytokine profile in schizophrenic patients. HAB 2018;27:23
    https://doi.org/10.3233/HAB-180344
  64. Ariane Mwema, Giulio G. Muccioli, Anne des Rieux. Innovative drug delivery strategies to the CNS for the treatment of multiple sclerosis. Journal of Controlled Release 2023;364:435
    https://doi.org/10.1016/j.jconrel.2023.10.052
  65. Elżbieta Kozłowska, Paulina Żelechowska, Adam Wysokiński, Paweł Rasmus, Anna Łucka, Ewa Brzezińska-Błaszczyk. In vitro cytokine synthesis in unstimulated and mitogen-stimulated peripheral blood mononuclear cells from individuals with schizophrenia. Journal of Investigative Medicine 2019;67:1053
    https://doi.org/10.1136/jim-2018-000964
  66. Larissa Daniele Bobermin, Amanda da Silva, Diogo Onofre Souza, André Quincozes‐Santos. Differential effects of typical and atypical antipsychotics on astroglial cells in vitro. Intl J of Devlp Neuroscience 2018;69:1
    https://doi.org/10.1016/j.ijdevneu.2018.06.001
  67. Giuseppe De Simone, Benedetta Mazza, Licia Vellucci, Annarita Barone, Mariateresa Ciccarelli, Andrea de Bartolomeis. Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment. Antioxidants 2023;12:975
    https://doi.org/10.3390/antiox12040975
  68. Tyler A. Lesh, Milo Careaga, Destanie R. Rose, A. Kimberley McAllister, Judy Van de Water, Cameron S. Carter, Paul Ashwood. Cytokine alterations in first-episode schizophrenia and bipolar disorder: relationships to brain structure and symptoms. J Neuroinflammation 2018;15
    https://doi.org/10.1186/s12974-018-1197-2
  69. Andrea de Bartolomeis, Licia Vellucci, Annarita Barone, Mirko Manchia, Vincenzo De Luca, Felice Iasevoli, Christoph U. Correll. Clozapine’s multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia. Pharmacology & Therapeutics 2022;236:108236
    https://doi.org/10.1016/j.pharmthera.2022.108236
  70. Alireza Vakilian, Seyed Moein Razavi-Nasab, Ali Ravari, Tayebeh Mirzaei, Amir Moghadam-Ahmadi, Nazanin Jalali, Reza Bahramabadi, Mohammadtaghi Rezayati, Amin Yazdanpanah-Ravari, Farhad Bahmaniar, Mohammad Reza Bagheri, Mahmood Sheikh Fathollahi, Gholamreza Asadikaram, Mohammad Kazemi Arababadi. Vitamin B12 in Association with Antipsychotic Drugs Can Modulate the Expression of Pro-/Anti-Inflammatory Cytokines in Alzheimer Disease Patients. Neuroimmunomodulation 2017;24:310
    https://doi.org/10.1159/000486597
  71. H.M. Abelaira, A.B. de Moura, M.M. Cardoso, E. de Pieri, J.S. Abel, G.P. Luiz, E.M. Sombrio, L.A. Borghezan, R.S. Anastácio, L.A. Cruz, T.G. de Souza, Corrêa MEAB, I.R. Lima, C. da Costa, A.G. Dal Bó, Silveira PCL, R.A. Machado-de-Ávila. Sertraline associated with gold nanoparticles reduce cellular toxicity and induce sex-specific responses in behavior and neuroinflammation biomarkers in a mouse model of anxiety. Pharmacology Biochemistry and Behavior 2023;233:173661
    https://doi.org/10.1016/j.pbb.2023.173661
  72. Margherita Nosadini, Stefano Sartori, Suvasini Sharma, Russell C. Dale. Immunotherapeutics in Pediatric Autoimmune Central Nervous System Disease: Agents and Mechanisms. Seminars in Pediatric Neurology 2017;24:214
    https://doi.org/10.1016/j.spen.2017.08.002
  73. Britta Stapel, Irina Sieve, Christine S. Falk, Stefan Bleich, Denise Hilfiker-Kleiner, Kai G. Kahl. Second generation atypical antipsychotics olanzapine and aripiprazole reduce expression and secretion of inflammatory cytokines in human immune cells. Journal of Psychiatric Research 2018;105:95
    https://doi.org/10.1016/j.jpsychires.2018.08.017
  74. Andrea de Bartolomeis, Licia Vellucci, Annarita Barone, Mirko Manchia, Vincenzo De Luca, Felice Iasevoli, Christoph Correll. Clozapine's Multiple Cellular Mechanisms: What Do We Know after More than Fifty Years? a Systematic Review and Critical Assessment of Translational Mechanisms Relevant for Innovative Strategies in Treatment-Resistant Schizophrenia. SSRN Journal 2022
    https://doi.org/10.2139/ssrn.4089530
  75. J. Y. Guo, T. A. Lesh, T. A. Niendam, J. D. Ragland, L. M. Tully, C. S. Carter. Brain free water alterations in first-episode psychosis: a longitudinal analysis of diagnosis, course of illness, and medication effects. Psychol. Med. 2021;51:1001
    https://doi.org/10.1017/S0033291719003969
  76. Monire Karbalaee, Melika Jameie, Mobina Amanollahi, Fateme TaghaviZanjani, Mohammadamin Parsaei, Fatemeh A. Basti, Saba Mokhtari, Kamyar Moradi, Mohammad-Reza Khodaei Ardakani, Shahin Akhondzadeh. Efficacy and safety of adjunctive therapy with fingolimod in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial. Schizophrenia Research 2023;254:92
    https://doi.org/10.1016/j.schres.2023.02.020
  77. Borbála Pethő, Márton Áron Kovács, Diána Simon, Tünde Tóth, András Sándor Hajnal, Tímea Csulak, Dóra Hebling, Noémi Albert, Eszter Varga, Márton Herold, Péter Osváth, Viktor Vörös, Tamás Tényi, Róbert Herold. Investigation of peripheral inflammatory biomarkers in association with suicide risk in major depressive disorder. Front. Psychiatry 2024;15
    https://doi.org/10.3389/fpsyt.2024.1321354
  78. Maria Fiorentino, Anna Sapone, Stefania Senger, Stephanie S. Camhi, Sarah M. Kadzielski, Timothy M. Buie, Deanna L. Kelly, Nicola Cascella, Alessio Fasano. Blood–brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders. Molecular Autism 2016;7
    https://doi.org/10.1186/s13229-016-0110-z
  79. I. K. Malashenkova, S. A. Krynskiy, D. P. Ogurtsov, M. V. Mamoshina, N. V. Zakharova, V. L. Ushakov, B. M. Velichkovsky, N. A. Didkovsky. A role of the immune system in the pathogenesis of schizophrenia. Z. nevrol. psikhiatr. im. S.S. Korsakova 2018;118:72
    https://doi.org/10.17116/jnevro201811812172
  80. Seunghyun Jeon, Se Hyun Kim, Soon Young Shin, Young Han Lee. Clozapine reduces Toll-like receptor 4/NF-κB-mediated inflammatory responses through inhibition of calcium/calmodulin-dependent Akt activation in microglia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2018;81:477
    https://doi.org/10.1016/j.pnpbp.2017.04.012
  81. Yunting Zhu, Samantha J. Owens, Caitlin E. Murphy, Kachikwulu Ajulu, Debora Rothmond, Tertia Purves-Tyson, Frank Middleton, Maree J. Webster, Cynthia Shannon Weickert. Inflammation-related transcripts define “high” and “low” subgroups of individuals with schizophrenia and bipolar disorder in the midbrain. Brain, Behavior, and Immunity 2022;105:149
    https://doi.org/10.1016/j.bbi.2022.06.012
  82. Lia Lira Olivier Sanders, Carlos Eduardo de Souza Menezes, Adriano José Maia Chaves Filho, Glautemberg de Almeida Viana, Francisco Vagnaldo Fechine, Maria Goretti Rodrigues de Queiroz, Said Gonçalvez da Cruz Fonseca, Silvânia Maria Mendes Vasconcelos, Maria Elisabete Amaral de Moraes, Clarissa S. Gama, Sheila Seybolt, Eugênio de Moura Campos, Danielle Macêdo, David Freitas de Lucena. α-Lipoic Acid as Adjunctive Treatment for Schizophrenia. J Clin Psychopharmacol 2017;37:697
    https://doi.org/10.1097/JCP.0000000000000800
  83. J.F. Olcina Rodríguez, J. Díaz Fernández, Nieves Orta Mira, E. López-Briz, Fernando Gómez-Pajares. Neutrophil/lymphocyte ratio: Can a non-specific marker of inflammation helps to confirm the inflammatory hypothesis of the serious mental diseases? A case-control study. Medical Hypotheses 2019;130:109279
    https://doi.org/10.1016/j.mehy.2019.109279
  84. Jaśmina Arabska, Adam Wysokiński, Ewa Brzezińska-Błaszczyk, Elżbieta Kozłowska. Serum Levels and in vitro CX3CL1 (Fractalkine), CXCL8, and IL-10 Synthesis in Phytohemaglutinin-Stimulated and Non-stimulated Peripheral Blood Mononuclear Cells in Subjects With Schizophrenia. Front. Psychiatry 2022;13
    https://doi.org/10.3389/fpsyt.2022.845136
  85. Adonis Sfera. Six Decades of Dopamine Hypothesis: Is Aryl Hydrocarbon Receptor the New D2?. Reports 2023;6:36
    https://doi.org/10.3390/reports6030036
  86. Hiram Tendilla-Beltrán, Nydia del Carmen Sanchez-Islas, Mauricio Marina-Ramos, Juan C. Leza, Gonzalo Flores. The prefrontal cortex as a target for atypical antipsychotics in schizophrenia, lessons of neurodevelopmental animal models. Progress in Neurobiology 2021;199:101967
    https://doi.org/10.1016/j.pneurobio.2020.101967
  87. Alexandre Vallée, Jean-Noël Vallée, Yves Lecarpentier. Lithium and Atypical Antipsychotics: The Possible WNT/β Pathway Target in Glaucoma. Biomedicines 2021;9:473
    https://doi.org/10.3390/biomedicines9050473
  88. S Kim, Y Hwang, M J Webster, D Lee. Differential activation of immune/inflammatory response-related co-expression modules in the hippocampus across the major psychiatric disorders. Mol Psychiatry 2016;21:376
    https://doi.org/10.1038/mp.2015.79
  89. Rebecca Fitton, Jennifer Sweetman, William Heseltine-Carp, Christina van der Feltz-Cornelis. Anti-inflammatory medications for the treatment of mental disorders: A scoping review. Brain, Behavior, & Immunity - Health 2022;26:100518
    https://doi.org/10.1016/j.bbih.2022.100518
  90. Ebru Fındıklı, Mehmet Akif Camkurt, Filiz İzci, Mehmet Fatih Karaaslan, Hüseyin Avni Fındıklı, Perihan Sümer, Ergül Belge Kurutaş. The Diagnostic Value of Malondialdehyde, Superoxide Dismutase and Catalase Activity in Drug Naïve, First Episode, Non-Smoker Generalized Anxiety Disorder Patients. Clin Psychopharmacol Neurosci 2018;16:88
    https://doi.org/10.9758/cpn.2018.16.1.88
  91. Dara Gammon, Catherine Cheng, Anna Volkovinskaia, Glen B. Baker, Serdar M. Dursun. Clozapine: Why Is It So Uniquely Effective in the Treatment of a Range of Neuropsychiatric Disorders?. Biomolecules 2021;11:1030
    https://doi.org/10.3390/biom11071030
  92. Jason Smucny, Cameron S. Carter, Richard J. Maddock. Greater Choline-Containing Compounds and Myo-inositol in Treatment-Resistant Versus Responsive Schizophrenia: A 1H-Magnetic Resonance Spectroscopy Meta-analysis. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 2024;9:137
    https://doi.org/10.1016/j.bpsc.2023.10.008
  93. Heather K. Hughes, Houa Yang, Tyler A. Lesh, Cameron S. Carter, Paul Ashwood. Evidence of innate immune dysfunction in first-episode psychosis patients with accompanying mood disorder. J Neuroinflammation 2022;19
    https://doi.org/10.1186/s12974-022-02648-y
  94. Sergej Nadalin, Hrvoje Jakovac, Vjekoslav Peitl, Dalibor Karlović, Alena Buretić‑Tomljanović. Dysregulated inflammation may predispose patients with serious mental illnesses to severe COVID‑19 (Review). Mol Med Rep 2021;24
    https://doi.org/10.3892/mmr.2021.12250
  95. Tina Notter. Biomarkers in Psychiatry. 2021.
    https://doi.org/10.1007/7854_2018_43
  96. Shrujna Patel, Brooke A. Keating, Russell C. Dale. Anti-inflammatory properties of commonly used psychiatric drugs. Front. Neurosci. 2023;16
    https://doi.org/10.3389/fnins.2022.1039379
  97. Marco Solmi, Nicola Veronese, Angela Favaro, Paolo Santonastaso, Enzo Manzato, Giuseppe Sergi, Christoph U. Correll. Inflammatory cytokines and anorexia nervosa: A meta-analysis of cross-sectional and longitudinal studies. Psychoneuroendocrinology 2015;51:237
    https://doi.org/10.1016/j.psyneuen.2014.09.031
  98. William E. Yang, Sunil Suchindran, Bradly P. Nicholson, Micah T. McClain, Thomas Burke, Geoffrey S. Ginsburg, Clayton D. Harro, Subhra Chakraborty, David A. Sack, Christopher W. Woods, Ephraim L. Tsalik. Transcriptomic Analysis of the Host Response and Innate Resilience to EnterotoxigenicEscherichia coliInfection in Humans. J Infect Dis. 2016;213:1495
    https://doi.org/10.1093/infdis/jiv593
  99. Andrea de Bartolomeis, Annarita Barone, Licia Vellucci, Benedetta Mazza, Mark C. Austin, Felice Iasevoli, Mariateresa Ciccarelli. Linking Inflammation, Aberrant Glutamate-Dopamine Interaction, and Post-synaptic Changes: Translational Relevance for Schizophrenia and Antipsychotic Treatment: a Systematic Review. Mol Neurobiol 2022;59:6460
    https://doi.org/10.1007/s12035-022-02976-3
  100. Afnan Al Abadey, Bronwen Connor, Anne Camille La Flamme, Katharina Robichon. Clozapine reduces chemokine-mediated migration of lymphocytes by targeting NF-κB and AKT phosphorylation. Cellular Signalling 2022;99:110449
    https://doi.org/10.1016/j.cellsig.2022.110449
  101. Arnaud Gacouin, Adel Maamar, Pierre Fillatre, Emmanuelle Sylvestre, Margaux Dolan, Yves Le Tulzo, Jean Marc Tadié. Patients with preexisting psychiatric disorders admitted to ICU: a descriptive and retrospective cohort study. Ann. Intensive Care 2017;7
    https://doi.org/10.1186/s13613-016-0221-x
  102. Marco Ferrari, Marco Godio, Stefano Martini, Camilla Callegari, Marco Cosentino, Franca Marino. Inflammatory markers at baseline correlate with subsequent clinical response to quetiapine in patients with bipolar disorder. Human Psychopharmacology 2022;37
    https://doi.org/10.1002/hup.2854
  103. Guillaume Fond, Katlyn Nemani, Damien Etchecopar-Etchart, Anderson Loundou, Donald C. Goff, Seung Won Lee, Christophe Lancon, Pascal Auquier, Karine Baumstarck, Pierre-Michel Llorca, Dong Keon Yon, Laurent Boyer. Association Between Mental Health Disorders and Mortality Among Patients With COVID-19 in 7 Countries. JAMA Psychiatry 2021;78:1208
    https://doi.org/10.1001/jamapsychiatry.2021.2274
  104. Ivo Emílio da Cruz Jung, Alencar Kolinski Machado, Ivana Beatrice Mânica da Cruz, Fernanda Barbisan, Verônica Farina Azzolin, Thiago Duarte, Marta Maria Medeiros Frescura Duarte, Pedro Antônio Schmidt do Prado-Lima, Guilherme Vargas Bochi, Gustavo Scola, Rafael Noal Moresco. Haloperidol and Risperidone at high concentrations activate an in vitro inflammatory response of RAW 264.7 macrophage cells by induction of apoptosis and modification of cytokine levels. Psychopharmacology 2016;233:1715
    https://doi.org/10.1007/s00213-015-4079-7
  105. Nikki Templeton, Bronwyn Kivell, Amy McCaughey-Chapman, Bronwen Connor, Anne Camille La Flamme, Fernando de Castro. Clozapine administration enhanced functional recovery after cuprizone demyelination. PLoS ONE 2019;14:e0216113
    https://doi.org/10.1371/journal.pone.0216113
  106. Mehmet Akif Camkurt, Fatih Karababa, Mehmet Emin Erdal, Hüseyin Bayazıt, Sultan Basmacı Kandemir, Mustafa Ertan Ay, Hasan Kandemir, Özlem İzci Ay, Erdinç Çiçek, Salih Selek, Bahar Taşdelen. Investigation of Dysregulation of Several MicroRNAs in Peripheral Blood of Schizophrenia Patients. Clin Psychopharmacol Neurosci 2016;14:256
    https://doi.org/10.9758/cpn.2016.14.3.256
  107. Musaad A. Alshammari, Tahani K. Alshammari. COVID-19: A new challenge for mental health and policymaking recommendations. Journal of Infection and Public Health 2021;14:1065
    https://doi.org/10.1016/j.jiph.2021.05.020